4//SEC Filing
Asterias Biotherapeutics, Inc. 4
Accession 0001140361-17-026472
CIK 0001572552operating
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 4:07 PM ET
Size
12.8 KB
Accession
0001140361-17-026472
Insider Transaction Report
Form 4
Spink Katharine E.
Vice President & COO
Transactions
- Award
Stock Option
2017-06-26+50,000→ 50,000 totalExercise: $3.70Exp: 2027-06-26→ Common Stock (50,000 underlying)
Holdings
- 192,500
Stock Option
Exercise: $2.34Exp: 2020-03-09→ Common Stock (192,500 underlying) - 150,000
Stock Options
Exercise: $3.45Exp: 2027-03-30→ Common Stock (150,000 underlying) - 165,000
Stock Option
Exercise: $3.64Exp: 2026-02-26→ Common Stock (165,000 underlying) - 100,000
Stock Option
Exercise: $3.90Exp: 2025-02-12→ Common Stock (100,000 underlying) - 10,949
Common Stock
- 100,000
Stock Option
Exercise: $5.45Exp: 2025-11-04→ Common Stock (100,000 underlying)
Footnotes (6)
- [F1]Subject to Ms. Spink's continued employment with the Company, 25% of the stock options vest on the one year anniversary of the grant date and the remaining 75% of the options vests monthly over 36 months. The stock options are exercisable upon vesting.
- [F2]Of such stock options, 4,167 have vested not as of the date hereof. The stock options are exercisable upon vesting.
- [F3]Of such stock options, 41,668 have vested not as of the date hereof. The stock options are exercisable upon vesting.
- [F4]Of such stock options, 62,500 have vested not as of the date hereof. The stock options are exercisable upon vesting.
- [F5]Of such stock options, 110,000 have not vested as of the date hereof. The stock options are exercisable upon vesting.
- [F6]Of such stock options, 150,000 have not vested as of the date hereof. The stock options are exercisable upon vesting.
Documents
Issuer
Asterias Biotherapeutics, Inc.
CIK 0001572552
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001572552
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 4:07 PM ET
- Size
- 12.8 KB